The rise of Viagra and its influence on the drug landscape presents a complicated question for shareholders. While the initial sales figures were astounding, the exclusivity has ended, leading to a deluge of off-brand https://marcsyge557341.mdkblog.com/47534284/the-blue-pill-and-the-pharmaceutical-industry-a-dangerous-investment